The separations market accounts for 17% of the total analytical and life sciences instrumentation industry and increased 1.5% to $7.6 billion in 2013. Demand was mainly driven by the aftermarket and service, while demand for initial systems increased about 1% for the year. Capital expenditures by industrial segments, such as pharmaceutical and chemical markets, were […]
Thermo and Life The pending merger (see IBO 4/15/13) will create an industry behemoth and creates new challenges for competitors, such as those in the lab distribution market. It also will provide Thermo with a commanding position as a supplier to pharmaceutical and biotechnology companies for both instruments and consumables. The integration process will be […]
Another Rough Year Last year was a challenging year for analytical instrument makers in many respects. Slower industrial markets and the US government sequestration, which curtailed demand from government and academic markets, resulted in modest sales growth for many companies. Chinese sales growth slowed overall and, although Europe stabilized, sales growth was uneven. Some companies […]
The instrument industry’s performance in 2013 was even more disappointing than in 2012, as a modest rebound was anticipated. Widespread economic malaise and disruptive budgeting decisions, especially in the US, generated considerable uncertainty about future business prospects. Such uncertainty negatively impacted lab capital expenditures. The very real economic effects of budget sequestration in the US […]
All four IBO Stock Indexes recorded strong double-digit gains in 2013 to end at record levels. Returns for the IBO Stock Indexes were the strongest since 2009, following the recession. Just as strong were US equity markets, which celebrated one of their best years ever and the best returns in six years despite modest economic […]
On November 21, the European Commission approved its 2014–20 budget, including €78.6 billion ($103.4 billion = €0.76 = $1) in funding for Horizon 2020, the EU’s primary research program. Horizon 2020 replaces the 7th Research Framework Programme and incorporates funding for the European Institute of Innovation and Technology and parts of the Competitiveness and Innovation […]
Third quarter revenues for IBO’s Lab Equipment/Consumables Sales Index grew 1.4%, 2.8% excluding currency, to $4,060 million. Operating profits for the Index rose 3.9% to $699 million. Based on continuing operations, operating margin expanded 40 basis points to 18.2% of sales. Kewaunee Scientific’s fiscal second quarter 2014 sales ending October 31 contracted 16.3% to $26.1 […]
Almost always, an analytical technology can meet the needs of different end-user markets. However, the successful transition of a technology from one market, in which it may be well established, to an entirely new and different market is often a precise and dedicated process. In this article, IBO examines three research technologies that have made […]
Third quarter sales for the Life Science Index grew 3.2%, 5.5% excluding currency, to $3,366 million. Operating profit improved 2.7% to $675 million. Based on continuing operations, operating margin slipped 20 basis points to 21.3% of sales. Fiscal fourth quarter revenue for Becton Dickinson’s BD Biosciences segment advanced 10.0%, 11.6% excluding currency, to $300 million […]
R&D spending by US universities declined 3.3% in fiscal year 2012 (FY12) in constant 2005 dollars to $34.6 billion—the first decline in 38 years. Adjusted for inflation, federal government academic R&D spending fell 1.6% to $40,130 million. However, excluding the federal government, R&D spending by US universities rose 4.7% to $25,644 million adjusted for inflation. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
